Does BPC-157 help with inflammation?
Reviewers summarise the preclinical studies as showing lower inflammatory cytokines, so the evidence is from animals rather than people.
Gastric pentadecapeptideUpdated
Short answer
Reviewers summarise the preclinical studies as showing lower inflammatory cytokines, so the evidence is from animals rather than people.[1]
An originating-group review reports that the peptide counteracted raised interleukin-6 and tumour necrosis factor in animal cachexia models.[2]
Animal models
In a rat model of gum disease, treatment reduced fluid leakage, tissue changes and bone loss around the teeth.[3]
In rats with chemically induced colitis, untreated controls failed to heal while the treated animals did.[4]
More questions on BPC-157
More on BPC-157
Sources
- 1Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025PMID 40756949Accessed 2 Oct 2026
- 2Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future.Gut and liver · 2020PMID 31158953Accessed 11 Oct 2026
- 3Antiinflammatory effect of BPC 157 on experimental periodontitis in rats.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2009PMID 20388954Accessed 2 Oct 2026
- 4Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2013PMID 24304574Accessed 2 Oct 2026
Found an error? Report a correction.